A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

ClinicalTrials.gov ID: NCT05201781

Public ClinicalTrials.gov record NCT05201781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 10, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Study identification

NCT ID: NCT05201781
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 295 participants

Conditions and interventions

Conditions

Multiple Myeloma

Interventions

Cilta-cel Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 8, 2022
Primary completion: Jul 28, 2037
Completion: May 31, 2042
Last update posted: May 7, 2026

2022 – 2042

United States locations

U.S. sites: 28
U.S. states: 18
U.S. cities: 24

Facility	City	State	ZIP	Site status
Mayo Clinic Cancer Center-Scottsdale	Phoenix	Arizona	85054	Recruiting
City of Hope	Duarte	California	91010	Recruiting
University of California San Francisco	San Francisco	California	94143	Recruiting
Stanford University Medical Center	Stanford	California	94305-5623	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Emory University	Atlanta	Georgia	30322	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
University of Chicago	Chicago	Illinois	60637	Recruiting
Indiana University	Indianapolis	Indiana	46202	Recruiting
Kansas University Medical Center	Westwood	Kansas	66205	Recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02115	Recruiting
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02215	Recruiting
Barbara Ann Karmanos Cancer Institute	Detroit	Michigan	48201	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55902	Recruiting
Washington University School Of Medicine	St Louis	Missouri	63110	Recruiting
Hackensack University Medical Center	Hackensack	New Jersey	07601	Recruiting
Rutgers Cancer Institute of New Jersey	New Brunswick	New Jersey	08903	Recruiting
Roswell Park Cancer Institute	Buffalo	New York	14263	Recruiting
Mount Sinai Medical Center	New York	New York	10029	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Montefiore Medical Center	The Bronx	New York	10467	Recruiting
Levine Cancer Institute	Charlotte	North Carolina	28204	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15232	Recruiting
Sarah Cannon Research Institute	Nashville	Tennessee	37203	Recruiting
MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Froedtert Memorial	Milwaukee	Wisconsin	53226	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05201781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05201781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →